Literature DB >> 10222245

Hypothalamic hypocretin/orexin and neuropeptide Y: divergent interaction with energy depletion and leptin.

B Beck1, S Richy.   

Abstract

The aim of this study was to measure the effects of chronic leptin treatment on two orexigenic peptides present in the hypothalamus namely hypocretin/orexin and neuropeptide Y (NPY). For this purpose, recombinant murine leptin (0.2 mg/rat/day) or saline were injected intraperitoneally in Long-Evans rats for 7 consecutive days. Food intake (-8%; p < 0.002) and body weight gain (23.7 +/- 1 vs 31.5 +/- 1.3 g; p < 0.003) were significantly lower in leptin-treated rats than the saline-treated rats. NPY concentrations did not change significantly in any of the microdissected brain areas including the arcuate and paraventricular nuclei. Orexin A concentration in the lateral hypothalamus was significantly decreased by the leptin treatment (-68%; p < 0.01). A smaller decrease (-46%; p < 0.04) was also noted in saline-treated rats pairfed to the level of the leptin-treated rats. We conclude that orexin/hypocretin could be considered as a new relay for leptin in the central nervous system. Its variation in case of lower energy supply observed in pairfed rats could constitute an alerting system for the brain and therefore considered as the first step in the establishment of defense mechanisms against energy depletion. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10222245     DOI: 10.1006/bbrc.1999.0605

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Promising new approaches to the management of obesity.

Authors:  I L Mertens; L F Van Gaal
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 2.  Appetite and energy balance signals from adipocytes.

Authors:  Paul Trayhurn; Chen Bing
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

3.  alpha-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression.

Authors:  C Fekete; G Légrádi; E Mihály; Q H Huang; J B Tatro; W M Rand; C H Emerson; R M Lechan
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

Review 4.  Orexin/hypocretin and dysregulated eating: Promotion of foraging behavior.

Authors:  Jessica R Barson
Journal:  Brain Res       Date:  2018-08-17       Impact factor: 3.252

5.  Hyperphagia and obesity produced by arcuate injection of NPY-saporin do not require upregulation of lateral hypothalamic orexigenic peptide genes.

Authors:  Ai-Jun Li; Thu T Dinh; Sue Ritter
Journal:  Peptides       Date:  2008-06-05       Impact factor: 3.750

Review 6.  Orexins/Hypocretins: Key Regulators of Energy Homeostasis.

Authors:  Edward Milbank; Miguel López
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-10       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.